OTC : CAMRF

Camurus AB

$58.51 USD

$0 (0.0%)

Volume
100
Average Volume
113
Market Capitalization
$3.48B
P/E Ratio
53.87
Dividend Yield
0.00%
Price Target
Year High
$71.00
Year Low
$54.00
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$11.57
Company Overview

OTC

Sven Fredrik Tiberg

Medical - Pharmaceuticals

Healthcare

CAMRF

308

SE

USD

https://www.camurus.com

46 4 62 86 57 30

13217Q105

N/A

Liquidity Metrics

0.02

11.57

11.28

9.72

0.00

Sales & Valuation

$2.27B

16.44

8.32

45.44

13.64

Profitability

$12.26

$735.57M

30.45%

38.52%

15.54%

12.78%

P/E Metrics

53.87

-8.02

-8.02

Analyst Price Target & Rating

N/A

0/5

0 Analysts

%

Financial Health Scores

34.39

5/9

$4.43B

$5.31B

$626.04M

$864.76M

Key Metrics (TTM)

$32.88B

14.50

37.16

10.01

15.54%

13.34%

1.84%

1.78%

$142.01

219 days

Company Executives
Name Title
Maria Lundqvist Global Head of Human Resources
Bo A. C. TarrasWahlberg Vice President of Legal & Group General Counsel
Anders Fink Vadsholt Chief Financial Officer
Richard Jameson Chief Commercial Officer
Susanne Lagerlund Vice President of Technical Operations
Markus Johnsson Senior Vice President of R&D
Rein Piir Vice President of Investor Relations
Jane Buus Laursen Chief Corporate Development Officer
Fredrik Joabsson Chief Business Development Officer
Fredrik Tiberg President, Chief Executive Officer, CSO & Director
Poll Results

No votes yet today — be the first to share your view!

About Camurus AB (OTC:CAMRF) Stock

Camurus AB operates as a research based pharmaceutical company. The firm engages in the research, development and commercialization of specialty medicines. It provides its products for the treatment of severe and chronic conditions, which includes opioid dependence, pain, cancer and endocrine disorders. The company was founded by Kare Larsson in 1991 and is headquartered in Lund, Sweden. ...

Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA

2026-07-17 01:22:00

PDUFA target action date set to 18 December 2026 LUND, Sweden, July 17, 2026 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the US Food and Drug Administration (FDA) has accepted for review the resubmission of the New Drug Application (NDA) for CAM2029, octreotide extended-release injection, for the treatment of patients with acromegaly. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date of 18 December 2026.

Camurus AB (publ) (CAMRF) Q2 2026 Earnings Call Transcript

2026-07-15 12:47:58

Camurus AB (publ) (CAMRF) Q2 2026 Earnings Call Transcript

Camurus' hormone disorder drug expected to be approved in 2027 after fresh FDA setback

2026-06-11 09:14:37

Wall Street has pushed to next year expectations for a U.S. approval for Camurus' ​drug to treat a rare hormonal condition after the health ‌regulator's second refusal on Wednesday.

Camurus announces expansion of Lilly collaboration

2026-06-01 11:33:00

LUND, Sweden, June 1, 2026 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that Eli Lilly and Company ("Lilly") has exercised its option to include amylin receptor agonists (amylin) in the collaboration and license agreement entered in June 2025. The decision extends Lilly's exclusive, global rights to Camurus' FluidCrystal® technology for the development and commercialization of long acting cardiometabolic drug medicines to an additional compound class.

Camurus AB (publ) (CAMRF) Q1 2026 Earnings Call Transcript

2026-05-12 15:20:49

Camurus AB (publ) (CAMRF) Q1 2026 Earnings Call Transcript

Frequently Asked Questions

What is the current Camurus AB (CAMRF) stock price?

Camurus AB(OTC:CAMRF) stock price is $58.51 in the last trading session. During the trading session, CAMRF stock reached the peak price of $71 while $54 was the lowest point it dropped to. The percentage change in CAMRF stock occurred in the recent session was 0.0% while the dollar amount for the price change in CAMRF stock was $0.

CAMRF's industry and sector of operation?

The OTC listed CAMRF is part of Medical - Pharmaceuticals industry that operates in the broader Healthcare sector.

Who are the executives of CAMRF?

Maria Lundqvist | Global Head of Human Resources
Bo A. C. TarrasWahlberg | Vice President of Legal & Group General Counsel
Anders Fink Vadsholt | Chief Financial Officer
Richard Jameson | Chief Commercial Officer
Susanne Lagerlund | Vice President of Technical Operations

How many employees does CAMRF have?

Number of CAMRF employees currently stands at 308. CAMRF operates from Rydbergs torg 4, Lund, SN 223 70, SE.

Link for CAMRF official website?

Official Website of CAMRF is: https://www.camurus.com

How do I contact CAMRF?

CAMRF could be contacted at phone #46 4 62 86 57 30 and can also be accessed through its website. CAMRF operates from Rydbergs torg 4, Lund, SN 223 70, SE.

How many shares of CAMRF are traded daily?

The average number of CAMRF shares traded daily for last 3 months was 113.

What is the market cap of CAMRF currently?

The market value of CAMRF currently stands at $3.48B with its latest stock price at $58.51